Basic Research in Cardiology

, 109:400

The RIPOST-MI study, assessing remote ischemic perconditioning alone or in combination with local ischemic postconditioning in ST-segment elevation myocardial infarction

  • Fabrice Prunier
  • Denis Angoulvant
  • Christophe Saint Etienne
  • Emmanuelle Vermes
  • Martine Gilard
  • Christophe Piot
  • François Roubille
  • Meyer Elbaz
  • Michel Ovize
  • Loïc Bière
  • Julien Jeanneteau
  • Stéphane Delépine
  • Thomas Benard
  • Wissam Abi-Khalil
  • Alain Furber
Original Contribution

Abstract

Local ischemic postconditioning (IPost) and remote ischemic perconditioning (RIPer) are promising cardioprotective therapies in ST-elevation myocardial infarction (STEMI). We aimed: (1) to investigate whether RIPer initiated at the catheterization laboratory would reduce infarct size, as measured using serum creatine kinase-MB isoenzyme (CK-MB) release as a surrogate marker; (2) to assess if the combination of RIPer and IPost would provide an additional reduction. Patients (n = 151) were randomly allocated to one of the following groups: (1) control group, percutaneous transluminal coronary angioplasty (PTCA) alone; (2) RIPer group, PTCA combined with RIPer, consisting of three cycles of 5-min inflation and 5-min deflation of an upper-arm blood-pressure cuff initiated before reperfusion; (3) RIPer+IPost group, PTCA combined with RIPer and IPost, consisting of four cycles of 1-min inflation and 1-min deflation of the angioplasty balloon. The CK-MB area under the curve (AUC) over 72 h was reduced in RIPer, and RIPer+IPost groups, by 31 and 29 %, respectively, compared to the Control group; however, CK-MB AUC differences between the three groups were not statistically significant (p = 0.06). Peak CK-MB, CK-MB AUC to area at risk (AAR) ratio, and peak CK-MB level to AAR ratio were all significantly reduced in the RIPer and RIPer+IPost groups, compared to the Control group. On the contrary, none of these parameters was significantly different between RIPer+IPost and RIPer groups. To conclude, starting RIPer therapy immediately prior to revascularization was shown to reduce infarct size in STEMI patients, yet combining this therapy with an IPost strategy did not lead to further decrease in infarct size.

Keywords

Cardioprotection Remote conditioning Reperfusion injury 

References

  1. 1.
    Ali ZA, Callaghan CJ, Lim E, Ali AA, Nouraei SA, Akthar AM, Boyle JR, Varty K, Kharbanda RK, Dutka DP, Gaunt ME (2007) Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116:I98–I105. doi:10.1161/circulationaha.106.679167 PubMedCrossRefGoogle Scholar
  2. 2.
    Boengler K, Buechert A, Heinen Y, Roeskes C, Hilfiker-Kleiner D, Heusch G, Schulz R (2008) Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circ Res 102:131–135. doi:10.1161/CIRCRESAHA.107.164699 PubMedCrossRefGoogle Scholar
  3. 3.
    Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R (2008) The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther 120:172–185. doi:10.1016/j.pharmthera.2008.08.002 PubMedCrossRefGoogle Scholar
  4. 4.
    Boengler K, Hilfiker-Kleiner D, Heusch G, Schulz R (2010) Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion. Basic Res Cardiol 105:771–785. doi:10.1007/s00395-010-0124-1 PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Botker HE, Kharbanda R, Schmidt MR, Bottcher M, Kaltoft AK, Terkelsen CJ, Munk K, Andersen NH, Hansen TM, Trautner S, Lassen JF, Christiansen EH, Krusell LR, Kristensen SD, Thuesen L, Nielsen SS, Rehling M, Sorensen HT, Redington AN, Nielsen TT (2010) Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial. Lancet 375:727–734. doi:10.1016/S0140-6736(09)62001-8 PubMedCrossRefGoogle Scholar
  6. 6.
    Brevoord D, Kranke P, Kuijpers M, Weber N, Hollmann M, Preckel B (2012) Remote ischemic conditioning to protect against ischemia-reperfusion injury: a systematic review and meta-analysis. PLoS ONE 7:e42179. doi:10.1371/journal.pone.0042179 PubMedCentralPubMedCrossRefGoogle Scholar
  7. 7.
    Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN (2006) Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 47:2277–2282. doi:10.1016/j.jacc.2006.01.066 PubMedCrossRefGoogle Scholar
  8. 8.
    Feild BJ, Russell RO Jr, Dowling JT, Rackley CE (1972) Regional left ventricular performance in the year following myocardial infarction. Circulation 46:679–689PubMedCrossRefGoogle Scholar
  9. 9.
    Frobert O, Lagerqvist B, Olivecrona GK, Omerovic E, Gudnason T, Maeng M, Aasa M, Angeras O, Calais F, Danielewicz M, Erlinge D, Hellsten L, Jensen U, Johansson AC, Karegren A, Nilsson J, Robertson L, Sandhall L, Sjogren I, Ostlund O, Harnek J, James SK (2013) Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med 369:1587–1597. doi:10.1056/NEJMoa1308789 PubMedCrossRefGoogle Scholar
  10. 10.
    Grall S, Prunier-Mirebeau D, Tamareille S, Mateus V, Lamon D, Furber A, Prunier F (2013) Endoplasmic reticulum stress pathway involvement in local and remote myocardial ischemic conditioning. Shock 39:433–439. doi:10.1097/SHK.0b013e31828e4f80 PubMedCrossRefGoogle Scholar
  11. 11.
    Hahn JY, Song YB, Kim EK, Yu CW, Bae JW, Chung WY, Choi SH, Choi JH, Bae JH, An KJ, Park JS, Oh JH, Kim SW, Hwang JY, Ryu JK, Park HS, Lim DS, Gwon HC (2013) Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial. Circulation 128:1889–1896. doi:10.1161/CIRCULATIONAHA.113.001690 PubMedCrossRefGoogle Scholar
  12. 12.
    Hausenloy DJ, Baxter G, Bell R, Botker HE, Davidson SM, Downey J, Heusch G, Kitakaze M, Lecour S, Mentzer R, Mocanu MM, Ovize M, Schulz R, Shannon R, Walker M, Walkinshaw G, Yellon DM (2010) Translating novel strategies for cardioprotection: the Hatter Workshop recommendations. Basic Res Cardiol 105:677–686. doi:10.1007/s00395-010-0121-4 PubMedCentralPubMedCrossRefGoogle Scholar
  13. 13.
    Hausenloy DJ, Lecour S, Yellon DM (2011) Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. Antioxid Redox Signal 14:893–907. doi:10.1089/ars2010.3360 PubMedCrossRefGoogle Scholar
  14. 14.
    Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM (2007) Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 370:575–579. doi:10.1016/S0140-6736(07)61296-3 PubMedCrossRefGoogle Scholar
  15. 15.
    Hausenloy DJ, Yellon DM (2008) Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res 79:377–386. doi:10.1093/cvr/cvn114 PubMedCrossRefGoogle Scholar
  16. 16.
    Hausenloy DJ, Yellon DM (2006) Survival kinases in ischemic preconditioning and postconditioning. Cardiovasc Res 70:240–253. doi:10.1016/j.cardiores.2006.01.017 PubMedCrossRefGoogle Scholar
  17. 17.
    Heusch G (2013) Cardioprotection: chances and challenges of its translation to the clinic. Lancet 381:166–175. doi:10.1016/S0140-6736(12)60916-7 PubMedCrossRefGoogle Scholar
  18. 18.
    Heusch G, Boengler K, Schulz R (2010) Inhibition of mitochondrial permeability transition pore opening: the Holy Grail of cardioprotection. Basic Res Cardiol 105:151–154. doi:10.1007/s00395-009-0080-9 PubMedCrossRefGoogle Scholar
  19. 19.
    Heusch G, Musiolik J, Gedik N, Skyschally A (2011) Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circ Res 109:1302–1308. doi:10.1161/CIRCRESAHA.111.255604 PubMedCrossRefGoogle Scholar
  20. 20.
    Heusch G, Musiolik J, Kottenberg E, Peters J, Jakob H, Thielmann M (2012) STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circ Res 110:111–115. doi:10.1161/CIRCRESAHA.111.259556 PubMedCrossRefGoogle Scholar
  21. 21.
    Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O’Sullivan M, Dutka DP (2009) Cardiac remote ischemic preconditioning in coronary stenting (CRISP Stent) study: a prospective, randomized control trial. Circulation 119:820–827. doi:10.1161/CIRCULATIONAHA.108.809723 PubMedCrossRefGoogle Scholar
  22. 22.
    Iliodromitis EK, Kyrzopoulos S, Paraskevaidis IA, Kolocassides KG, Adamopoulos S, Karavolias G, Kremastinos DT (2006) Increased C reactive protein and cardiac enzyme levels after coronary stent implantation. Is there protection by remote ischaemic preconditioning? Heart 92:1821–1826. doi:10.1136/hrt.2006.089060 PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Jeanneteau J, Hibert P, Martinez MC, Tual-Chalot S, Tamareille S, Furber A, Andriantsitohaina R, Prunier F (2012) Microparticle release in remote ischemic conditioning mechanism. Am J Physiol Heart Circ Physiol 303:H871–H877. doi:10.1152/ajpheart.00102.2012 PubMedCrossRefGoogle Scholar
  24. 24.
    Juhaszova M, Zorov DB, Kim SH, Pepe S, Fu Q, Fishbein KW, Ziman BD, Wang S, Ytrehus K, Antos CL, Olson EN, Sollott SJ (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113:1535–1549. doi:10.1172/JCI19906 PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Kaur S, Jaggi AS, Singh N (2009) Molecular aspects of ischaemic postconditioning. Fundam Clin Pharmacol 23:521–536. doi:10.1111/j.1472-8206.2009.00733.x PubMedCrossRefGoogle Scholar
  26. 26.
    Kharbanda RK (2010) Cardiac conditioning: a review of evolving strategies to reduce ischaemia-reperfusion injury. Heart 96:1179–1186. doi:10.1136/hrt.2009.179101 PubMedCrossRefGoogle Scholar
  27. 27.
    Kharbanda RK, Mortensen UM, White PA, Kristiansen SB, Schmidt MR, Hoschtitzky JA, Vogel M, Sorensen K, Redington AN, MacAllister R (2002) Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 106:2881–2883PubMedCrossRefGoogle Scholar
  28. 28.
    Kharbanda RK, Nielsen TT, Redington AN (2009) Translation of remote ischaemic preconditioning into clinical practice. Lancet 374:1557–1565. doi:10.1016/S0140-6736(09)61421-5 PubMedCrossRefGoogle Scholar
  29. 29.
    Kottenberg E, Thielmann M, Bergmann L, Heine T, Jakob H, Heusch G, Peters J (2012) Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol: a clinical trial. Acta Anaesthesiol Scand 56:30–38. doi:10.1111/j.1399-6576.2011.02585.x PubMedCrossRefGoogle Scholar
  30. 30.
    Lacerda L, Somers S, Opie LH, Lecour S (2009) Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway. Cardiovasc Res 84:201–208. doi:10.1093/cvr/cvp274 PubMedCrossRefGoogle Scholar
  31. 31.
    Lonborg J, Kelbaek H, Vejlstrup N, Jorgensen E, Helqvist S, Saunamaki K, Clemmensen P, Holmvang L, Treiman M, Jensen JS, Engstrom T (2010) Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance. Circ Cardiovasc Interv 3:34–41. doi:10.1161/CIRCINTERVENTIONS.109.905521 PubMedCrossRefGoogle Scholar
  32. 32.
    Ovize M, Baxter GF, Di Lisa F, Ferdinandy P, Garcia-Dorado D, Hausenloy DJ, Heusch G, Vinten-Johansen J, Yellon DM, Schulz R (2010) Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 87:406–423. doi:10.1093/cvr/cvq129 PubMedCrossRefGoogle Scholar
  33. 33.
    Ovize M, Thibault H, Przyklenk K (2013) Myocardial conditioning: opportunities for clinical translation. Circ Research 113:439–450. doi:10.1161/CIRCRESAHA.113.300764 CrossRefGoogle Scholar
  34. 34.
    Pell TJ, Baxter GF, Yellon DM, Drew GM (1998) Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. Am J Physiol 275:H1542–H1547PubMedGoogle Scholar
  35. 35.
    Przyklenk K, Bauer B, Ovize M, Kloner RA, Whittaker P (1993) Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87:893–899PubMedCrossRefGoogle Scholar
  36. 36.
    Rentoukas I, Giannopoulos G, Kaoukis A, Kossyvakis C, Raisakis K, Driva M, Panagopoulou V, Tsarouchas K, Vavetsi S, Pyrgakis V, Deftereos S (2010) Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action. JACC Cardiovasc Interv 3:49–55. doi:10.1016/j.jcin.2009.10.015 PubMedCrossRefGoogle Scholar
  37. 37.
    Saxena P, Newman MA, Shehatha JS, Redington AN, Konstantinov IE (2010) Remote ischemic conditioning: evolution of the concept, mechanisms, and clinical application. J Card Surg 25:127–134. doi:10.1111/j.1540-8191.2009.00820.x PubMedCrossRefGoogle Scholar
  38. 38.
    Skyschally A, Walter B, Heusch G (2013) Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning. Eur Heart J 34:3314–3321. doi:10.1093/eurheartj/ehs434 PubMedCrossRefGoogle Scholar
  39. 39.
    Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L’Huillier I, Aupetit JF, Bonnefoy E, Finet G, Andre-Fouet X, Ovize M (2005) Postconditioning the human heart. Circulation 112:2143–2148. doi:10.1161/CIRCULATIONAHA.105.558122 PubMedCrossRefGoogle Scholar
  40. 40.
    Tamareille S, Ghaboura N, Treguer F, Khachman D, Croue A, Henrion D, Furber A, Prunier F (2009) Myocardial reperfusion injury management: erythropoietin compared with postconditioning. Am J Physiol Heart Circ Physiology 297:H2035–H2043. doi:10.1152/ajpheart.00472.2009 CrossRefGoogle Scholar
  41. 41.
    Tamareille S, Mateus V, Ghaboura N, Jeanneteau J, Croue A, Henrion D, Furber A, Prunier F (2011) RISK and SAFE signaling pathway interactions in remote limb ischemic perconditioning in combination with local ischemic postconditioning. Basic Res Cardiol 106:1329–1339. doi:10.1007/s00395-011-0210-z PubMedCrossRefGoogle Scholar
  42. 42.
    Thibault H, Piot C, Staat P, Bontemps L, Sportouch C, Rioufol G, Cung TT, Bonnefoy E, Angoulvant D, Aupetit JF, Finet G, Andre-Fouet X, Macia JC, Raczka F, Rossi R, Itti R, Kirkorian G, Derumeaux G, Ovize M (2008) Long-term benefit of postconditioning. Circulation 117:1037–1044. doi:10.1161/CIRCULATIONAHA.107.729780 PubMedCrossRefGoogle Scholar
  43. 43.
    Thielmann M, Kottenberg E, Boengler K, Raffelsieper C, Neuhaeuser M, Peters J, Jakob H, Heusch G (2010) Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest. Basic Res Cardiol 105:657–664. doi:10.1007/s00395-010-0104-5 PubMedCrossRefGoogle Scholar
  44. 44.
    Thielmann M, Kottenberg E, Kleinbongard P, Wendt D, Gedik N, Pasa S, Price V, Tsagakis K, Neuhauser M, Peters J, Jakob H, Heusch G (2013) Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial. Lancet 382:597–604. doi:10.1016/S0140-6736(13)61450-6 PubMedCrossRefGoogle Scholar
  45. 45.
    Venugopal V, Hausenloy DJ, Ludman A, Di Salvo C, Kolvekar S, Yap J, Lawrence D, Bognolo J, Yellon DM (2009) Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial. Heart 95:1567–1571. doi:10.1136/hrt.2008.155770 PubMedCrossRefGoogle Scholar
  46. 46.
    Vlaar PJ, Svilaas T, van der Horst IC, Diercks GF, Fokkema ML, de Smet BJ, van den Heuvel AF, Anthonio RL, Jessurun GA, Tan ES, Suurmeijer AJ, Zijlstra F (2008) Cardiac death and reinfarction after 1 year in the thrombus aspiration during percutaneous coronary intervention in acute myocardial infarction Study (TAPAS): a 1-year follow-up study. Lancet 371:1915–1920. doi:10.1016/S0140-6736(08)60833-8 PubMedCrossRefGoogle Scholar
  47. 47.
    Wagner R, Piler P, Bedanova H, Adamek P, Grodecka L, Freiberger T (2010) Myocardial injury is decreased by late remote ischaemic preconditioning and aggravated by tramadol in patients undergoing cardiac surgery: a randomised controlled trial. Interact Cardiovasc Thorac Surg 11:758–762. doi:10.1510/icvts.2010.243600 PubMedCrossRefGoogle Scholar
  48. 48.
    Walsh SR, Boyle JR, Tang TY, Sadat U, Cooper DG, Lapsley M, Norden AG, Varty K, Hayes PD, Gaunt ME (2009) Remote ischemic preconditioning for renal and cardiac protection during endovascular aneurysm repair: a randomized controlled trial. J Endovasc Ther 16:680–689. doi:10.1583/09-2817.1 PubMedCrossRefGoogle Scholar
  49. 49.
    Weinbrenner C, Schulze F, Sarvary L, Strasser RH (2004) Remote preconditioning by infrarenal aortic occlusion is operative via delta1-opioid receptors and free radicals in vivo in the rat heart. Cardiovasc Res 61:591–599. doi:10.1016/j.cardiores.2003.10.008 PubMedCrossRefGoogle Scholar
  50. 50.
    Wolfrum S, Schneider K, Heidbreder M, Nienstedt J, Dominiak P, Dendorfer A (2002) Remote preconditioning protects the heart by activating myocardial PKCepsilon-isoform. Cardiovasc Res 55:583–589. doi:S000863630200408X PubMedCrossRefGoogle Scholar
  51. 51.
    Xin P, Zhu W, Li J, Ma S, Wang L, Liu M, Wei M, Redington AN (2010) Combined local ischemic postconditioning and remote perconditioning recapitulate cardioprotective effects of local ischemic preconditioning. Am J Physiol Heart Circ Physiol 298:H1819–H1831. doi:10.1152/ajpheart.01102.2009 PubMedCrossRefGoogle Scholar
  52. 52.
    Xue F, Yang X, Zhang B, Zhao C, Song J, Jiang T, Jiang W (2010) Postconditioning the human heart in percutaneous coronary intervention. Clin Cardiol 33:439–444. doi:10.1002/clc.20796 PubMedCrossRefGoogle Scholar
  53. 53.
    Yellon DM, Hausenloy DJ (2007) Myocardial reperfusion injury. N Engl J Med 357:1121–1135. doi:10.1056/NEJMra071667 PubMedCrossRefGoogle Scholar
  54. 54.
    Zhao ZQ, Corvera JS, Halkos ME, Kerendi F, Wang NP, Guyton RA, Vinten-Johansen J (2003) Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol 285:H579–H588. doi:10.1152/ajpheart.01064.2002 PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Fabrice Prunier
    • 1
  • Denis Angoulvant
    • 2
  • Christophe Saint Etienne
    • 2
  • Emmanuelle Vermes
    • 2
  • Martine Gilard
    • 3
  • Christophe Piot
    • 4
  • François Roubille
    • 4
  • Meyer Elbaz
    • 5
  • Michel Ovize
    • 6
  • Loïc Bière
    • 1
  • Julien Jeanneteau
    • 1
  • Stéphane Delépine
    • 1
  • Thomas Benard
    • 1
  • Wissam Abi-Khalil
    • 1
  • Alain Furber
    • 1
  1. 1.Service de Cardiologie, EA 3860, Laboratoire Cardioprotection, Remodelage et ThromboseUniversité Angers, CHU AngersAngersFrance
  2. 2.Service de Cardiologie, EA 4245, Cellules Dendritiques Immunomodulation et GreffesUniversité François Rabelais de Tours, CHRU de ToursToursFrance
  3. 3.Service de CardiologieUniversité Brest, CHU BrestBrestFrance
  4. 4.Service de CardiologieUniversité 1 Montpellier, CHU MontpellierMontpellierFrance
  5. 5.Service de CardiologieUniversité Toulouse, CHU ToulouseToulouseFrance
  6. 6.Service d’Explorations Fonctionnelles Cardiovasculaires, Inserm U1060-CarMeN, CIC de LyonUniversité Claude Bernard Lyon1, Hôpital Louis PradelLyonFrance

Personalised recommendations